Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-21-030618)

Filing Details

Accession Number:: 0001213900-21-030618
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-02 17:38:47
Reporting Period:: 2021-06-01

Accepted Time:: 2021-06-02 17:38:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1726711	Aditx Therapeutics Inc.	ADTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1479091	W. Jeffrey Runge	C/O Aditx Therapeutics, Inc. 2569 Wyandotte St., Suite 101 Mountain View CA 94043		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-01	700	$2.94	3,200	No	4	P	Direct
Common Stock	Acquisiton	2021-06-01	700	$2.94	3,900	No	4	P	Direct
Common Stock	Acquisiton	2021-06-01	1,600	$2.93	5,500	No	4	P	Direct
Common Stock	Acquisiton	2021-06-01	2,000	$2.93	7,500	No	4	P	Direct
Common Stock	Acquisiton	2021-06-01	2,000	$2.93	9,500	No	4	P	Direct
Common Stock	Acquisiton	2021-06-01	3,000	$2.94	12,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct